Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Session History
Support Wiki
Direct access to
document ID:

          Institute: MPI für Dynamik komplexer technischer Systeme     Collection: Bioprocess Engineering     Display Documents

ID: 317137.0, MPI für Dynamik komplexer technischer Systeme / Bioprocess Engineering
Analysis of Growth Dynamics in a Three-Species Chemostat by Disturbing Coexistence with Antibiotic Pulse
Authors:Riedele, C.; Schmidt, J. K.; Reichl, U.
Name of Conference/Meeting:European BioPerspectives 2007
Place of Conference/Meeting:Cologne, Germany
(Start) Date of Event 
End Date of Conference/Meeting 
Audience:Experts Only
Abstract / Description:From clinical data is known that treatment with antibiotics against Staphylococcus aureus, a bacterium that occurs in the first years in the life of CF-patients, leads to an earlier infection with the more pathogenic Pseudomonas aeruginosa [1]. The reasons for this effect are unknown.
In our previous studies, a chemostat culture with three bacterial species relevant for cystic fibrosis (CF): P. aeruginosa, S. aureus and Burkholderia cepacia, was set up as a model system for microbial communities occurring in the lung of CF patients. In chemostat experiments with stationary conditions the coexistence of at least two of the species was observed. A quantitative T-RFLP method was adapted to monitor the specific cell number in mixed cultures of P. aeruginosa, S. aureus and B. cepacia [2]. The experimental work was supported by mathematical modelling, indicating a possible cause of coexistence on the basis of a food chain [3].
Based on this work and motivated by antibiotic therapies of CF patients, the dynamics of the mixed chemostat culture by setting antibiotic pulses will be investigated in the study presented here. The results from the model system will be compared to antibiotic pulse experiments in pure culture. This should lead to a better understanding of the behaviour of microbial communities on antibiotic treatment in contrast to pure cultures which are routinely used in antibiotic screening. It is expected that useful hints for the effect observed in antibiotic therapies of CF related infections can be derived from the results as well.
First results of experiments are presented including establishment of quantification methods. Ceftazidim, the applied antibiotic, will be determined in culture broth by reversed phase HPLC. The susceptibility of ceftazidim to the different bacterial species will be tested, using a minimum inhibition concentration (MIC) assay. The adapted quantitative T-RFLP analyses will be further optimized in a way that intact but dead cells are separated from intact but viable cells and therefore do not appear in the calculation of the cell number.

[1] Ratjen F., Döring G.: Lancet (2003), 361: 681-689
[2] Schmidt J.K., et al.: Biotechnology and Bioengineering, accepted Aug. 2006
[3] Heßeler J., et al.: Journal of Mathematical Biology (2006): 53: 556-584
Document Type:Poster
Communicated by:Udo Reichl
Affiliations:MPI für Dynamik komplexer technischer Systeme/Bioprocess Engineering
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.